Channing J. Der, PhD
- The Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis, Leslie B. Gordon, Francis S. Collins, Thomas Glover, Michael W. Glynn, Brian C. Capell, Adrienne D. Cox; and Channing J. Der, Patent Number 7,838,531, November 23, 2010
- Peptides binding SH3 domain of cortatin and their use, Brian K. Kay, Andrew B. Sparks, Judith M. Thorn, Lawrence A. Quilliam, Channing J. Der, Dana M. Fowlkes, and James E. Rider, European Patent Number 897392, November 17, 2004
- Src SH3 binding peptides and methods of isolating and using same, Brian K. Kay, Andrew B. Sparks, Judith M. Thorn, Lawrence A. Quilliam, and Channing J. Der; U.S. Patent Number 6,703,482, March 9, 2004
- Nck SH3 binding peptides, Andrew B. Sparks, Brian K. Kay, Judith M. Thorn; Lawrence A. Quilliam; Channing J. Der, Dana M. Fowlkes, and James E. Rider; Patent Number 6,432,920, August 13, 2002
- Src SH3 binding peptides and methods of isolating and using same, Brian K. Kay, Andrew B. Sparks, Lawrence A. Quilliam, and Channing J. Der; U.S. Patent Number 6,303,574, October 16, 2001
- Grb2 SH3 binding peptides and methods of isolating and using same, Andrew B. Sparks, Brian K. Kay, Judith M. Thorn; Lawrence A. Quilliam; Channing J. Der, Dana M. Fowlkes, and James E. Rider; U.S. Patent Number 6,184,205, February 6, 2001
- Shc proteins, Channing J. Der, John P. O’Bryan, and Anthony Pawson, U.S. Patent Number 6,077,686, June 20, 2000
Der Lab 